You are here
New drug for peripheral and cutaneous T-cell lymphomas
Sharan Prakash Sharma
The Lancet Oncology, Volume 15, Issue 6, May 2014, Pages e200
Mogamulizumab, a CC chemokine receptor (CCR4) antibody, could provide a novel treatment option for patients with relapsed peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL) according to a new study .